Navigation Links
DS Chemphy Focusing on CRO/CMO Business
Date:2/9/2010

WILMINGTON, Del., Feb. 9 /PRNewswire/ -- The rapid increase of cost in China has brought some shadow to the CRO and CMO businesses there. However, DS Chemphy, Inc., a USA-based contract research and manufacturing organization that focuses on fine and pharmaceutical chemicals, continues investing in its businesses. "Our competitive advantages are not only low costs," said Dr. Aaron Shen, CEO of the company.

Dr. Shen continues: "What makes Chemphy so attractive to our customers? The answers are: high-standard EHS management, high quality products and services, proprietary technologies, high efficiency, excellent IP protection, active communication, and integrated capability from R&D to manufacture."

Since DS Chemphy acquired New Chemphy in 2007, DS Chemphy has invested over $45 million in CRO/CMO capability as well as corporate culture and management reform. New Chemphy was founded by the Chinese Academy of Sciences. DS Chemphy integrated Chinese and Western advantages, i.e. lower costs of China and high-standard quality management of the West. The successful story was reported by C&E News (Issue Sept 1, 2008, page 35).

Most senior executives of the company have overseas training or work experience. The company now employs over 1000 chemical professionals. Last year, the company built a world-class R&D center. 150 chemists, including 25 PhDs, work in the center. The labs are equipped with state-of-the-art instruments including NMR, LC-MS, GC-MS, DSC, RC1, and GPC. The company has two manufacturing sites capable of production at pilot, multi-functional, and commercial scale. The reactors cover all sizes up to 20M(3). The reactors are either made of stainless steel, or glass-lined, nickel-lined, titanium-lined, Hastelloy-lined or polytetrafluoroethylene-lined.

DS Chemphy offers quality products based on Chemphy proprietary technology platforms including cyclopropanation, fluorination, and catalytic continues process, etc.

Recently DS Chemphy launched three new products:

Cyclopentyl methyl ether -- THF alternative

ChemphySteel® -- Polymers as strong as steel

ChemphyFresh® -- Keep your fruits and vegetables fresh

Visit us at booth 117 at InformEx USA, San Francisco, CA February 16-19, 2010, or www.dschemphy.com. You may also contact Aaron Shen, President of DS Chemphy at tel: 302-351-8401, fax: 302-351-6101 or email: ashen@dschemphy.com.

SOURCE DS Chemphy, Inc.

RELATED LINKS
http://www.dschemphy.com

'/>"/>

SOURCE DS Chemphy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Immtech Focusing on Other Infectious Disease Programs Following Discontinuation of Development of Pafuramidine
2. EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimers, Schizophrenia and Huntingtons Diseases
3. Hopkins Report: Focusing on Family Planning Lessens HIV Impact
4. Babson Executive Education Offers Bio-Pharma: Mastering the Business of Science
5. Centerphase Solutions, Inc. Launches New Clinical Trials Business Model Company
6. Kantar Health and ImpactRx Launch CancerMPact Monthly Drugs and Regimens for Oncology Business Decisions
7. Los Angeles Business Owner Pleads Guilty to Submitting Nearly $1 Million in False and Fraudulent Claims to Medicare
8. Highlights of Economic and Business Growth in the Tampa Bay Region
9. Solos Endoscopy, Inc. Set to Increase Business Through Sales and Product Development in 2010
10. PDI Announces New Pharmaceutical Services Business Win With a Top 5 Pharmaceutical Company
11. Pfizer Whistleblower Named Years Most Influential Person In Business Ethics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, ... their offering. ... pharmacogenomics market was valued at US$ 7,167.6 Mn in 2015, ... expanding at a CAGR of 5.6% from 2016 to 2024. ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
Breaking Medicine Technology:
(Date:4/25/2017)... Fl (PRWEB) , ... April 25, 2017 , ... There ... Memorial Regional Hospital, according to a special report in the May issue of Consumer ... its highest quality ranking for results achieved during and after coronary bypass and ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG CNS ... Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national conference. ... pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit for ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... As part ... Museum today to honor the victims of the Holocaust and Nazi persecution, Center ... at Hadamar and Auschwitz on its CMATH Champions trip to Germany and Poland next ...
(Date:4/24/2017)... Calif. (PRWEB) , ... April 24, 2017 , ... The ... $1.6 million in charitable dental services to 1,961 people during the April 22-23 event ... at no charge to Californians who experience barriers to care, CDA Cares educates the ...
(Date:4/24/2017)... Boca Raton, Florida (PRWEB) , ... April 24, ... ... that develops a variety of unique liquid food supplements, announced its popular products ... of nutritional products. , ALP Nutrition® prioritizes the use of premium natural ...
Breaking Medicine News(10 mins):